why choose us

First received: October 18, 2022

Clinical Trial: Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Moderate-to-Severe Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients With Moderate-to-Severe Atopic Dermatitis

Brief Summary: The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis.Atopic dermatitis, also referred to as eczema, is a condition that causes the skin to become itchy, dry, and cracked.From the previous studies on the study drug, it is seen that the study drug has an acceptable safety and effectiveness in participants with atopic dermatitis.The aim of this study is to get additional information on the safety and effectiveness of the study drug, particularly the information on aspects…

Read more